InvestorsHub Logo
Followers 17
Posts 10841
Boards Moderated 0
Alias Born 03/11/2017

Re: None

Monday, 10/23/2017 7:07:35 AM

Monday, October 23, 2017 7:07:35 AM

Post# of 44784
Pluristem Expands its Reach in the Treatment of Impaired Hematopoietic Systems with a European Patent Covering PLX-R18 in Chemotherapy, ARS, Genetic Disorders and Autoimmune Diseases.


https://finance.yahoo.com/news/pluristem-expands-reach-treatment-impaired-110000165.html